Executive Advisor (EU)
Jim Furniss is an independent consultant advising companies on market access for pharmaceuticals in Europe, North America and the rest of the world.
Jim was a senior official in the UK Department of Health, responsible for the operation of the Pharmaceutical Price Regulation Scheme and for the NHS drug budget. He was also a member of the European Commission’s Pharmaceutical Pricing Transparency Committee.
Jim has subsequently spent 20 years in consultancy in the healthcare and pharmaceutical industry, working on a large number of pharmaceutical pricing, reimbursement and market access projects. This has included all major therapy areas, but with an emphasis on oncology and orphan drugs , including treatments for multiple myeloma – specifically lenalidomide and bortezomib.